Associations of Obesity Indices with Bone Mineral Densities and Risk of Osteoporosis Stratified Across Diabetic Vascular Disease in T2DM Patients

被引:5
作者
Zheng, Silan [1 ]
Zhou, Jingqi [1 ]
Wang, Kai [1 ]
Wang, Xinyue [2 ]
Li, Zhibin [3 ,6 ]
Chen, Ning [1 ,4 ,5 ]
机构
[1] Fudan Univ, Zhongshan Hosp, Xiamen Branch, Dept Endocrinol, Xiamen, Peoples R China
[2] Fudan Univ, Zhongshan Hosp, Xiamen Branch, Dept Clin Nutr, Xiamen, Peoples R China
[3] Xiamen Univ, Affiliated Hosp 1, Translat Med Res Ctr, Sch Med,Epidemiol Res Unit, Xiamen, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Endocrinol, Shanghai, Peoples R China
[5] Fudan Univ, Zhongshan Hosp, Xiamen Branch, Dept Endocrinol, 668 Jinhu Rd, Xiamen 361003, Peoples R China
[6] Xiamen Univ, Affiliated Hosp 1, Translat Med Res Ctr, Sch Med,Epidemiol Res Unit, 55 Zhenhai Rd, Xiamen 361003, Peoples R China
来源
DIABETES METABOLIC SYNDROME AND OBESITY | 2022年 / 15卷
基金
国家重点研发计划;
关键词
obesity; bone mineral density; osteoporosis; diabetic vascular complications; diabetes; FRACTURE RISK; MASS; MELLITUS; WOMEN; FAT;
D O I
10.2147/DMSO.S384266
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To evaluate associations of obesity indices with bone mineral densities (BMD) and risk of osteoporosis in T2DM patients totally and stratified across presence of any diabetic cardiovascular complications.Methods: Cross-sectional analyses of baseline information on a cohort of 250 T2DM patients were conducted in Xiamen, China. Obesity indices included body weight, height, body mass index (BMI), waist and waist hip ratio (WHR). BMD was measured using dual-energy X-ray absorptiometry at three different sites, and osteoporosis was defined based on the minimum T-scores of BMD. Presence of any diabetic vascular complications was confirmed by checking their medical records histories.Results: Among the 250 T2DM patients, 50 (20.0%) were defined as osteoporosis. Multivariable linear regression and multivariable logistic regression analyses showed that igher obesity indices, including body weight, BMI and waist, but neither body height nor waist hip ratio, were positively associated with the minimum T-scores of BMD and had significantly decreased risk of osteoporosis. Stratified analyses across presence of any of diabetic vascular complications showed similar results for those with any of diabetic vascular complications, while no significant association between obesity indices and minimum T-scores of BMD was found for those without. Postmenopausal women (vs men) and ever drinking were significantly associated with increased risk of osteoporosis, and the adjusted odds ratios (95% CIs) were 5.165 (1.762-15.138, p = 0.003) and 3.789 (1.087-13.214, p = 0.037), respectively. None of metabolic profiles, including systolic and diastolic blood pressure, triglyceride, total cholesterol, high-density lipoprotein cholesterol, HbA1c and blood uric acid, was significantly associated with either minimum T-scores of BMD or risk of osteoporosis.Conclusion: Associations of obesity indices with either BMD or risk of osteoporosis in T2DM patients varied by presence of any diabetic vascular complication and should be not interpreted as causal without considering the often-unmeasured effect modification by health status.
引用
收藏
页码:3459 / 3468
页数:10
相关论文
共 26 条
  • [1] A perspective on male osteoporosis
    Binkley, Neil
    [J]. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2009, 23 (06): : 755 - 768
  • [2] Divergent effects of obesity on fragility fractures
    Caffarelli, Carla
    Alessi, Chiara
    Nuti, Ranuccio
    Gonnelli, Stefano
    [J]. CLINICAL INTERVENTIONS IN AGING, 2014, 9 : 1629 - 1636
  • [3] Effects of obesity on bone metabolism
    Cao, Jay J.
    [J]. JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2011, 6
  • [4] Fat or lean tissue mass: Which one is the major determinant of bone mineral mass in healthy postmenopausal women?
    Chen, Z
    Lohman, TG
    Stini, WA
    Ritenbaugh, C
    Aickin, M
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (01) : 144 - 151
  • [5] Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW
    Compston, Juliet E.
    Watts, Nelson B.
    Chapurlat, Roland
    Cooper, Cyrus
    Boonen, Steven
    Greenspan, Susan
    Pfeilschifter, Johannes
    Silverman, Stuart
    Diez-Perez, Adolfo
    Lindsay, Robert
    Saag, Kenneth G.
    Netelenbos, J. Coen
    Gehlbach, Stephen
    Hooven, Frederick H.
    Flahive, Julie
    Adachi, Jonathan D.
    Rossini, Maurizio
    LaCroix, Andrea Z.
    Roux, Christian
    Sambrook, Philip N.
    Siris, Ethel S.
    [J]. AMERICAN JOURNAL OF MEDICINE, 2011, 124 (11) : 1043 - 1050
  • [6] Body mass index as a predictor of fracture risk:: A meta-analysis
    De Laet, C
    Kanis, JA
    Odén, A
    Johanson, H
    Johnell, O
    Delmas, P
    Eisman, JA
    Kroger, H
    Fujiwara, S
    Garnero, P
    McCloskey, EV
    Mellstrom, D
    Melton, LJ
    Meunier, PJ
    Pols, HAP
    Reeve, J
    Silman, A
    Tenenhouse, A
    [J]. OSTEOPOROSIS INTERNATIONAL, 2005, 16 (11) : 1330 - 1338
  • [7] Bone mineral density and fracture risk in type-2 diabetes mellitus: the Rotterdam Study.
    de Liefde, II
    van der Klift, M
    de Laet, CEDH
    van Daele, PLA
    Hofman, A
    Pols, HAP
    [J]. OSTEOPOROSIS INTERNATIONAL, 2005, 16 (12) : 1713 - 1720
  • [8] Sex and Gender Considerations in Male Patients With Osteoporosis
    Dy, Christopher J.
    LaMont, Lauren E.
    Ton, Quang V.
    Lane, Joseph M.
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2011, 469 (07) : 1906 - 1912
  • [9] Advanced Glycation Endproducts and Bone Material Strength in Type 2 Diabetes
    Furst, Jessica R.
    Bandeira, Leonardo C.
    Fan, Wen-Wei
    Agarwal, Sanchita
    Nishiyama, Kyle K.
    McMahon, Donald J.
    Dworakowski, Elzbieta
    Jiang, Hongfeng
    Silverberg, Shonni J.
    Rubin, Mishaela R.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (06) : 2502 - 2510
  • [10] EFFECT OF ESTROGEN ON CALCIUM-ABSORPTION AND SERUM VITAMIN-D METABOLITES IN POST-MENOPAUSAL OSTEOPOROSIS
    GALLAGHER, JC
    RIGGS, BL
    DELUCA, HF
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1980, 51 (06) : 1359 - 1364